LEADER 02128nas 2200661-a 450 001 996207321603316 005 20231222222503.0 011 $a1097-0231 035 $a(OCoLC)38172210 035 $a(CKB)954925574961 035 $a(CONSER)sn-97001401- 035 $a(DE-599)ZDB2002158-6 035 $a(EXLCZ)99954925574961 100 $a19980108a19879999 s-- a 101 0 $aeng 135 $aurmnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aRapid communications in mass spectrometry $eRCM 210 $aChichester ;$aNew York, NY $cJohn Wiley & Sons 215 $a1 online resource 300 $aRefereed/Peer-reviewed 311 $a0951-4198 330 $aAbstracts and full-text, 1997- ; abstracts only, 1996. 517 3 $aRCM 531 $aRAPID COMMUN MASS SPECTROM 531 $aRAPID COMMUN MASS SP 531 $aRAP C MASS 531 $aRAPID COMMUN MASS SPECTROSC 531 $aRAPID COMMUN. MASS SPECTROM 531 0 $aRapid commun. mass spectrom. 606 $aMass spectrometry$vPeriodicals 606 $aMass Spectrometry 606 $aSpectrométrie de masse$xPériodiques 606 $aSpectrométrie de masse$vPériodiques 606 $aSpectrométrie de masse 606 $amass spectrometry$2aat 606 $aMass spectrometry$2fast$3(OCoLC)fst01011435 608 $aPeriodical 608 $aperiodicals.$2aat 608 $aPeriodicals.$2fast 608 $aPeriodicals.$2lcgft 608 $aPériodiques.$2rvmgf 615 0$aMass spectrometry 615 2$aMass Spectrometry 615 6$aSpectrométrie de masse$xPériodiques. 615 6$aSpectrométrie de masse 615 6$aSpectrométrie de masse. 615 7$amass spectrometry. 615 7$aMass spectrometry. 676 $a543 712 12$aInternational Symposium on Applied Mass Spectrometry in the Health Sciences, 712 12$aEuropean Tandem Mass Spectrometry Conference, 906 $aJOURNAL 912 $a996207321603316 996 $aRapid communications in mass spectrometry$9790450 997 $aUNISA LEADER 02546nam 2200445z- 450 001 9910166645703321 005 20210211 035 $a(CKB)3710000001092142 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/43398 035 $a(oapen)doab43398 035 $a(EXLCZ)993710000001092142 100 $a20202102d2016 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aClinical Application of Stereotactic Body Radiotherapy (SBRT): Cranium to Prostate 210 $cFrontiers Media SA$d2016 215 $a1 online resource (85 p.) 225 1 $aFrontiers Research Topics 311 08$a2-88919-846-4 330 $aStereotactic radiosurgery is a relatively recent radiation technique initially developed using a frame-based system in 1949 by a Swedish neurosurgeon, Lars Leksell, for lesions not amendable to surgical resection. Radiosurgery is founded on principles of extreme radiation dose escalation, afforded by precise dose delivery with millimeter accuracy. Building upon the success of frame-based radiosurgery techniques, which were limited to cranial tumors and invasive head-frame placement, advances in radiation delivery and image-guidance have lead to the development of stereotactic body radiotherapy (SBRT). SBRT allows for frameless delivery of dose distributions akin to frame-based cranial stereotactic radiosurgery to both cranial and extra-cranial sites and has emerged as a important treatment strategy for a variety of cancers from the cranium to prostate. Herein we highlight ongoing investigations for the clinical application of SBRT for a variety of primary and recurrence cancers aimed at examining the growing clinical evidence supporting emerging roles for SBRT in the ever growing oncologic armamentarium. 517 $aClinical Application of Stereotactic Body Radiotherapy 606 $aMedicine$2bicssc 610 $aAdrenal metastases 610 $aCentral Nervous System 610 $aGynecologic 610 $ahead and neck 610 $aNon small cell lung cancer 610 $aProstate 610 $astereotactic body radiation therapy 610 $aStereotactic radiosurgery 615 7$aMedicine 700 $aDwight E. Heron$4auth$01280035 702 $aJohn Austin Vargo$4auth 906 $aBOOK 912 $a9910166645703321 996 $aClinical Application of Stereotactic Body Radiotherapy (SBRT): Cranium to Prostate$93016371 997 $aUNINA